rs12779955

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_145869.2(ANXA11):​c.-225A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 152,294 control chromosomes in the GnomAD database, including 1,205 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1205 hom., cov: 33)
Exomes 𝑓: 0.25 ( 0 hom. )

Consequence

ANXA11
NM_145869.2 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0170

Publications

6 publications found
Variant links:
Genes affected
ANXA11 (HGNC:535): (annexin A11) This gene encodes a member of the annexin family, a group of calcium-dependent phospholipid-binding proteins. Annexins have unique N-terminal domains and conserved C-terminal domains, which contain calcium-dependent phospholipid-binding sites. The encoded protein is a 56-kD antigen recognized by sera from patients with various autoimmune diseases. Several transcript variants encoding two different isoforms have been identified. [provided by RefSeq, Dec 2015]
ANXA11 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 23
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • inclusion body myopathy and brain white matter abnormalities
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.229 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_145869.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANXA11
NM_145868.2
MANE Select
c.-57-4953A>G
intron
N/ANP_665875.1P50995-1
ANXA11
NM_001278408.2
c.-225A>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 17NP_001265337.1P50995-1
ANXA11
NM_145869.2
c.-225A>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 17NP_665876.1P50995-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANXA11
ENST00000438331.5
TSL:1
c.-225A>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 17ENSP00000398610.1P50995-1
ANXA11
ENST00000438331.5
TSL:1
c.-225A>G
5_prime_UTR
Exon 2 of 17ENSP00000398610.1P50995-1
ANXA11
ENST00000422982.8
TSL:1 MANE Select
c.-57-4953A>G
intron
N/AENSP00000404412.2P50995-1

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17249
AN:
152172
Hom.:
1199
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0507
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.201
Gnomad ASJ
AF:
0.118
Gnomad EAS
AF:
0.0173
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.0918
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.130
GnomAD4 exome
AF:
0.250
AC:
1
AN:
4
Hom.:
0
Cov.:
0
AF XY:
0.250
AC XY:
1
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.113
AC:
17270
AN:
152290
Hom.:
1205
Cov.:
33
AF XY:
0.116
AC XY:
8635
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0506
AC:
2105
AN:
41576
American (AMR)
AF:
0.202
AC:
3088
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
409
AN:
3472
East Asian (EAS)
AF:
0.0173
AC:
90
AN:
5190
South Asian (SAS)
AF:
0.240
AC:
1157
AN:
4820
European-Finnish (FIN)
AF:
0.0918
AC:
973
AN:
10596
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.134
AC:
9081
AN:
68022
Other (OTH)
AF:
0.133
AC:
282
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
781
1561
2342
3122
3903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.133
Hom.:
961
Bravo
AF:
0.118
Asia WGS
AF:
0.144
AC:
500
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.3
DANN
Benign
0.52
PhyloP100
0.017
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12779955; hg19: chr10-81940864; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.